| scholarly article | Q13442814 |
| P2093 | author name string | Hamed Qutbuddeen | |
| J Al-Bishri | |||
| Nawal Bassuni | |||
| Salma Al-Harthi | |||
| Sarah Subahi | |||
| Sm Attar | |||
| Yasser Al-Nofaiey | |||
| P2860 | cites work | Acute non-infectious arthritis of the hip in rheumatoid arthritis: synovial membrane findings | Q41206680 |
| Effect of short-term, low-dose corticosteroids on plasma lipoprotein lipids | Q43591338 | ||
| Epidemiological aspects of rheumatoid arthritis: the sex ratio | Q44037479 | ||
| Importance of patient history and physical examination in rheumatoid arthritis compared to other chronic diseases: results of a physician survey | Q46353052 | ||
| Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis. | Q46852341 | ||
| Rheumatoid arthritis prevalence, incidence, and mortality rates: a nationwide population study in Taiwan. | Q51181626 | ||
| Sixty percent of patients with rheumatoid arthritis in Japan have used dietary supplements or health foods. | Q51652992 | ||
| Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in t | Q56966479 | ||
| [Health-related quality of life of patients with rheumatoid arthritis. Which factors are of significance?] | Q56974128 | ||
| Diagnosis of early rheumatoid arthritis: what the non-specialist needs to know | Q80512723 | ||
| [Nonsteroidal antirheumatics and hypertension] | Q84193823 | ||
| [Diagnosis and treatment of osteoporosis and rheumatoid arthritis in accordance with German guidelines. Results of a survey of patients, primary care physicians and rheumatologists] | Q84556672 | ||
| Diabetes mellitus risk in rheumatoid arthritis: reduced incidence with anti-tumor necrosis factor α therapy | Q85042756 | ||
| [Special features of coronary artery involvement in women with rheumatoid arthritis] | Q85271773 | ||
| Inflammation and insulin resistance | Q22241893 | ||
| 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis | Q26828418 | ||
| The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
| Morning stiffness in patients with early rheumatoid arthritis is associated more strongly with functional disability than with joint swelling and erythrocyte sedimentation rate | Q28279824 | ||
| Rheumatoid arthritis is caused by Proteus: the molecular mimicry theory and Karl Popper. | Q30377693 | ||
| Guidelines for prevention of NSAID-related ulcer complications | Q33412100 | ||
| Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature. | Q33530747 | ||
| Prescription patterns and appropriateness of NSAID therapy according to gastrointestinal risk and cardiovascular history in patients with diagnoses of osteoarthritis | Q33871754 | ||
| Relative importance of genetic effects in rheumatoid arthritis: historical cohort study of Danish nationwide twin population. | Q33953270 | ||
| COX-2 and beyond: Approaches to prostaglandin inhibition in human disease | Q34282832 | ||
| Incidence and risk factors of steroid-induced diabetes in patients with respiratory disease | Q34539990 | ||
| Common secondary causes of resistant hypertension and rational for treatment | Q34669789 | ||
| Extra-articular Manifestations in Rheumatoid Arthritis. | Q35154792 | ||
| Choice of Biologic Therapy for Patients with Rheumatoid Arthritis: The Infection Perspective | Q35237588 | ||
| Dyslipidemia and rheumatoid arthritis | Q35547301 | ||
| The effect of co-morbidities on health-related quality of life in patients placed on the waiting list for total joint replacement | Q35696840 | ||
| Prostanoids and blood pressure: which way is up? | Q35889642 | ||
| Autoimmune thyroid disease in rheumatoid arthritis: a global perspective | Q36421188 | ||
| Cardiovascular co-morbidity in rheumatic diseases | Q36835851 | ||
| Comorbidities in rheumatoid arthritis | Q36942648 | ||
| Clinical investigation in highly disease-affected rheumatoid arthritis patients in Japan with adalimumab applying standard and general evaluation: the CHANGE study | Q37157407 | ||
| Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice | Q37407637 | ||
| Estrogens in rheumatoid arthritis; the immune system and bone | Q37777882 | ||
| Diabetes mellitus and insulin resistance in patients with rheumatoid arthritis: risk reduction in a chronic inflammatory disease | Q37859679 | ||
| Co-morbidities in established rheumatoid arthritis. | Q37964309 | ||
| Summary of AHRQ's comparative effectiveness review of drug therapy for rheumatoid arthritis (RA) in adults--an update. | Q38015440 | ||
| Total shoulder arthroplasty in rheumatoid arthritis | Q39528123 | ||
| P921 | main subject | rheumatoid arthritis | Q187255 |
| comorbidity | Q1414874 | ||
| P304 | page(s) | 11-18 | |
| P577 | publication date | 2013-04-04 | |
| P1433 | published in | Clinical medicine insights. Arthritis and musculoskeletal disorders | Q27723438 |
| P1476 | title | Comorbidity profile among patients with rheumatoid arthritis and the impact on prescriptions trend | |
| P478 | volume | 6 |
| Q91510424 | Antirheumatic Medicine Prescribing Patterns and Direct Medicine Costs in the South African Private Health Sector |
| Q92737108 | Burden of rheumatoid arthritis among US Medicare population: co-morbidities, health-care resource utilization and costs |
| Q47320087 | Chronic disease list conditions in patients with rheumatoid arthritis in the private healthcare sector of South Africa. |
| Q30376057 | Co-morditities of environmental diseases: A common cause. |
| Q38990549 | Comparison of comorbidities of the Egyptian rheumatoid arthritis patients to the global cohort of the COMORA study: a post-hoc analysis. |
| Q36274355 | Drug usage analysis and health care resources consumption in naïve patients with rheumatoid arthritis |
| Q35236926 | Pattern of drugs use and association with anti-mutated citrullinated vimentin antibody in rheumatoid arthritis |
| Q35183717 | Rheumatoid arthritis in Saudi Arabia |
| Q47552951 | Rheumatoid arthritis: A single-center Egyptian experience. |
| Q39242725 | Tackling comorbidity associated with rheumatic diseases in standard practice |
Search more.